# Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects

> **NCT05786339** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 68 (actual)

## Conditions studied

- Therapeutic Equivalency

## Interventions

- **DRUG:** Tested Irbesartan Tablet
- **DRUG:** Reference Irbesartan Tablet

## Key facts

- **NCT ID:** NCT05786339
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-17
- **Primary completion:** 2019-01-16
- **Final completion:** 2019-05-15
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05786339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05786339, "Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05786339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*